Trinity Biotech (TRIB) Profit After Tax (2016 - 2024)
Historic Profit After Tax for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$17.0 million.
- Trinity Biotech's Profit After Tax fell 20816.07% to -$17.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$31.9 million, marking a year-over-year increase of 1428.3%. This contributed to the annual value of -$31.2 million for FY2024, which is 2996.92% down from last year.
- According to the latest figures from Q4 2024, Trinity Biotech's Profit After Tax is -$17.0 million, which was down 20816.07% from -$4.8 million recorded in Q3 2024.
- In the past 5 years, Trinity Biotech's Profit After Tax ranged from a high of $7.3 million in Q3 2020 and a low of -$18.6 million during Q2 2023
- Over the past 5 years, Trinity Biotech's median Profit After Tax value was -$5.2 million (recorded in 2023), while the average stood at -$4.9 million.
- Per our database at Business Quant, Trinity Biotech's Profit After Tax skyrocketed by 16377.39% in 2020 and then tumbled by 19166797.86% in 2023.
- Quarter analysis of 5 years shows Trinity Biotech's Profit After Tax stood at -$9.6 million in 2020, then skyrocketed by 58.65% to -$4.0 million in 2021, then plummeted by 152.63% to -$10.1 million in 2022, then surged by 45.42% to -$5.5 million in 2023, then crashed by 208.16% to -$17.0 million in 2024.
- Its last three reported values are -$17.0 million in Q4 2024, -$4.8 million for Q3 2024, and -$6.9 million during Q2 2024.